• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N-乙酰半胱氨酸对术后肝功能障碍的益处:病例报告及文献综述

Benefit of -Acetylcysteine in Postoperative Hepatic Dysfunction: Case Report and Review of Literature.

作者信息

Bauerlein Deanna K, Akbar Hashem N, von Rosenvinge Erik C, Loughry Nora D, John Preeti R

机构信息

Veterans Affairs New Jersey Healthcare System, USA.

Tufts University Medical Center, USA.

出版信息

Case Reports Hepatol. 2019 Dec 17;2019:4730381. doi: 10.1155/2019/4730381. eCollection 2019.

DOI:10.1155/2019/4730381
PMID:31934469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6942756/
Abstract

-Acetylcysteine (NAC) is reported to have multiple clinical applications in addition to being the specific antidote for acetaminophen toxicity. NAC stimulates glutathione biosynthesis, promotes detoxification, and acts directly as a scavenger of free radicals. It is a powerful antioxidant and a potential treatment option for diseases characterized by the generation of free oxygen radicals. We present a case of postoperative hepatic dysfunction of multifactorial etiology in a patient with therapeutic acetaminophen levels, where hepatic function improved considerably following administration of intravenous NAC. This case suggests that NAC should be considered for treatment of acute liver dysfunction in the postoperative setting, even in the absence of elevated acetaminophen levels.

摘要

乙酰半胱氨酸(NAC)除了是对乙酰氨基酚中毒的特效解毒剂外,还具有多种临床应用。NAC刺激谷胱甘肽的生物合成,促进解毒,并直接作为自由基清除剂发挥作用。它是一种强大的抗氧化剂,也是治疗以氧自由基产生为特征的疾病的潜在治疗选择。我们报告了一例术后肝功能不全的病例,病因多因素,患者对乙酰氨基酚水平处于治疗范围,静脉注射NAC后肝功能显著改善。该病例表明,即使对乙酰氨基酚水平未升高,术后急性肝功能不全的治疗也应考虑使用NAC。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd9/6942756/f7a8d5b2c013/CRIHEP2019-4730381.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd9/6942756/f7a8d5b2c013/CRIHEP2019-4730381.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/acd9/6942756/f7a8d5b2c013/CRIHEP2019-4730381.001.jpg

相似文献

1
Benefit of -Acetylcysteine in Postoperative Hepatic Dysfunction: Case Report and Review of Literature.N-乙酰半胱氨酸对术后肝功能障碍的益处:病例报告及文献综述
Case Reports Hepatol. 2019 Dec 17;2019:4730381. doi: 10.1155/2019/4730381. eCollection 2019.
2
Efficacy and safety of acetylcysteine in "non-acetaminophen" acute liver failure: A meta-analysis of prospective clinical trials.乙酰半胱氨酸在“非对乙酰氨基酚”急性肝衰竭中的疗效与安全性:前瞻性临床试验的荟萃分析
Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):594-9. doi: 10.1016/j.clinre.2015.01.003. Epub 2015 Feb 26.
3
N-acetylcysteine amide, a promising antidote for acetaminophen toxicity.N-乙酰半胱氨酸酰胺,一种有前景的对乙酰氨基酚中毒解毒剂。
Toxicol Lett. 2016 Jan 22;241:133-42. doi: 10.1016/j.toxlet.2015.11.008. Epub 2015 Nov 19.
4
Therapeutic effect of liposomal-N-acetylcysteine against acetaminophen-induced hepatotoxicity.脂质体 N-乙酰半胱氨酸对抗乙酰氨基酚诱导的肝毒性的治疗作用。
J Drug Target. 2013 May;21(5):466-73. doi: 10.3109/1061186X.2013.765443. Epub 2013 Apr 19.
5
Comparison of S-Adenosyl-L-methionine and N-acetylcysteine protective effects on acetaminophen hepatic toxicity.S-腺苷-L-甲硫氨酸与N-乙酰半胱氨酸对乙酰氨基酚肝毒性保护作用的比较
J Pharmacol Exp Ther. 2007 Jan;320(1):99-107. doi: 10.1124/jpet.106.111872. Epub 2006 Oct 25.
6
Improvement of therapeutic potential N-acetylcysteine in acetaminophen hepatotoxicity by encapsulation in PEGylated nano-niosomes.通过将 N-乙酰半胱氨酸封装在聚乙二醇化的纳米囊泡中,提高对乙酰氨基酚肝毒性的治疗潜力。
Life Sci. 2020 Aug 15;255:117832. doi: 10.1016/j.lfs.2020.117832. Epub 2020 May 22.
7
Late extensive intravenous administration of N-acetylcysteine can reverse hepatic failure in acetaminophen overdose.晚期大剂量静脉注射 N-乙酰半胱氨酸可逆转对乙酰氨基酚过量引起的肝衰竭。
Hum Exp Toxicol. 2011 Jan;30(1):51-4. doi: 10.1177/0960327110366182. Epub 2010 Mar 23.
8
Existing and potential therapeutic uses for N-acetylcysteine: the need for conversion to intracellular glutathione for antioxidant benefits.N-乙酰半胱氨酸的现有和潜在治疗用途:为获得抗氧化益处需要转化为细胞内谷胱甘肽。
Pharmacol Ther. 2014 Feb;141(2):150-9. doi: 10.1016/j.pharmthera.2013.09.006. Epub 2013 Sep 28.
9
Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure.N-乙酰半胱氨酸在非对乙酰氨基酚所致儿童急性肝衰竭中的安全性和有效性。
Liver Transpl. 2008 Jan;14(1):25-30. doi: 10.1002/lt.21246.
10
Prevention of acetaminophen-induced cataract by a combination of diallyl disulfide and N-acetylcysteine.二烯丙基二硫和N-乙酰半胱氨酸联合预防对乙酰氨基酚诱导的白内障
J Ocul Pharmacol Ther. 1998 Aug;14(4):345-55. doi: 10.1089/jop.1998.14.345.

引用本文的文献

1
Role of the AMPK/SIRT1 pathway in non‑alcoholic fatty liver disease (Review).AMPK/SIRT1 通路在非酒精性脂肪性肝病中的作用(综述)。
Mol Med Rep. 2023 Feb;27(2). doi: 10.3892/mmr.2022.12922. Epub 2022 Dec 23.

本文引用的文献

1
Role of N-acetylcysteine treatment in non-acetaminophen-induced acute liver failure: A prospective study.N-乙酰半胱氨酸治疗在非对乙酰氨基酚所致急性肝衰竭中的作用:一项前瞻性研究。
Saudi J Gastroenterol. 2017 May-Jun;23(3):169-175. doi: 10.4103/1319-3767.207711.
2
A Review on Various Uses of N-Acetyl Cysteine.N-乙酰半胱氨酸的多种用途综述
Cell J. 2017 Apr-Jun;19(1):11-17. doi: 10.22074/cellj.2016.4872. Epub 2016 Dec 21.
3
Acute hepatotoxicity associated with therapeutic doses of intravenous acetaminophen.与治疗剂量静脉注射对乙酰氨基酚相关的急性肝毒性。
Clin Toxicol (Phila). 2016 Mar;54(3):282-5. doi: 10.3109/15563650.2015.1134798. Epub 2016 Jan 14.
4
Possible hepatotoxicity associated with intravenous acetaminophen in a 36-year-old female patient.一名36岁女性患者静脉注射对乙酰氨基酚可能存在的肝毒性。
P T. 2015 Feb;40(2):123-32.
5
Oral and Intravenous Acetylcysteine for Treatment of Acetaminophen Toxicity: A Systematic Review and Meta-analysis.口服和静脉注射乙酰半胱氨酸治疗对乙酰氨基酚中毒:系统评价和荟萃分析。
West J Emerg Med. 2013 May;14(3):218-26. doi: 10.5811/westjem.2012.4.6885.
6
Improvements in hepatic serological biomarkers are associated with clinical benefit of intravenous N-acetylcysteine in early stage non-acetaminophen acute liver failure.肝血清学生物标志物的改善与早期非乙酰氨基酚性急性肝衰竭患者静脉用 N-乙酰半胱氨酸的临床获益相关。
Dig Dis Sci. 2013 May;58(5):1397-402. doi: 10.1007/s10620-012-2512-x. Epub 2013 Jan 17.
7
Hepatoprotective effects of antioxidants in chronic hepatitis C.抗氧化剂对慢性丙型肝炎的肝保护作用。
World J Gastroenterol. 2010 Apr 21;16(15):1937-8. doi: 10.3748/wjg.v16.i15.1937.
8
Pain management in the cirrhotic patient: the clinical challenge.肝硬化患者的疼痛管理:临床挑战。
Mayo Clin Proc. 2010 May;85(5):451-8. doi: 10.4065/mcp.2009.0534. Epub 2010 Mar 31.
9
N-acetylcysteine: multiple clinical applications.N-乙酰半胱氨酸:多种临床应用
Am Fam Physician. 2009 Aug 1;80(3):265-9.
10
Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.静脉注射N-乙酰半胱氨酸可提高早期非对乙酰氨基酚急性肝衰竭患者无移植生存率。
Gastroenterology. 2009 Sep;137(3):856-64, 864.e1. doi: 10.1053/j.gastro.2009.06.006. Epub 2009 Jun 12.